Chidamide for Refractory/Relapsed Peripheral T Cell Lymphoma
Clinical trial NCT02944812 · UNKNOWN
Trial details
- NCT number
- NCT02944812
- Sponsor
- Guangdong Provincial People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-01
- Primary completion
- 2019-01-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.